Approvals are valid for patients where the prescriber confirms the patient meets the following criteria and has endorsed the prescription accordingly:
All of the following:
Patient has confirmed (or probable) symptomatic COVID-19, or has symptoms consistent with COVID-19 and is a household contact of a positive case;
AND
Patient’s symptoms started within the last 5 days (if considering nirmatrelvir with ritonavir or molnupiravir) or within the last 7 days (if considering remdesivir);
AND
Patient does not require supplemental oxygen#;
AND
ANY of the following:
Patient is immunocompromised* and not expected to reliably mount an adequate immune response to COVID-19 vaccination or SARS-CoV-2 infection, regardless of vaccination status; or
Patient has Down syndrome; or
Patient has sickle cell disease; or
Patient has had a previous admission to Critical Care or High Dependency care directly as a result of COVID-19; or
Patient is aged 65 years or over; or
Patient is Māori or Pacific ethnicity AND aged 50 years or over; or
Patient is aged 50 years or over AND has not completed a primary course^ of COVID-19 vaccination; or
Patient has any combination of three or more high-risk medical conditions for severe illness from COVID-19 identified by Manatū Hauora - Ministry of Health**;
AND
Not to be used with other COVID-19 antiviral treatments.
人家写的是any of the following conditions 都可以,其中or是并列条件并不是从属条件,退一万步讲,就拿年龄来说你说的也是错的,人家写的是65岁以上,嘿嘿作者: lxz1990 时间: 2023-1-14 22:44:30